DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Yamagishi S, Takeuchi M, Inoue H.
Olmesartan medoxomil, a newly developed angiotensin II type 1 receptor antagonist, protects against renal damage in advanced glycation end product (age)-injected rats.
Drugs Exp Clin Res 2005;
31: 45-51
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.